BackAmicus Therapeutics Overview

Amicus Therapeutics Research & Development

Research & Development expenses for FOLD.

Quarterly R&D Expenses

$23.74M
↓ 21.36% YoY

As of Dec 31, 2025

Annual R&D Expenses (TTM)

$135.84M
↑ 24.21% YoY

Trailing 12 months ending Dec 31, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin